Neoplasm

Zubair Baloch, Guido Fadda, Christopher C. Griffith, Jerzy Klijanienko, Jeffrey F. Krane, Lester Layfield, Zahra Maleki, Ritu Nayar, Marc P. Pusztaszeri

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The diagnostic category “Neoplasm” is divided into two subcategories (1) Benign Neoplasm and (2) Salivary Gland Neoplasm of Uncertain Malignant Potential (SUMP). The former subcategory includes common benign neoplasms which are diagnosed with high specificities such as pleomorphic adenoma and Warthin tumor. Whereas, the latter includes tumors where a specific diagnosis and differentiation between a benign and usually low-grade malignant neoplasm is not possible due to inherent cytomorphologic features or limited cytologic material. FNA cases diagnosed as SUMP will mandate a differential diagnosis which includes both benign and malignant entities. In the MSRSGC, the risk of malignancy (based on the review of the literature) for the Benign Neoplasm and SUMP categories is <3% and 35%, respectively.

Original languageEnglish (US)
Title of host publicationThe Milan System for Reporting Salivary Gland Cytopathology, Second Edition
PublisherSpringer International Publishing
Pages71-103
Number of pages33
ISBN (Electronic)9783031266621
ISBN (Print)9783031266614
DOIs
StatePublished - Jan 1 2023

Keywords

  • Benign neoplasm
  • FNA
  • Risk of malignancy
  • Salivary gland
  • Salivary gland neoplasm of uncertain malignant potential

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Neoplasm'. Together they form a unique fingerprint.

Cite this